Price regulation and relative delays in generic drug adoption
Related Articles
-
Price regulation in the pharmaceutical industry: Prescription or placebo?
Pharma Live, , Regulatory Affairs, 0
1-s2-0-0167629695000224-mainDownload
-
Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients
Pharma Live, , Regulatory Affairs, 0
1-s2-0-s1319016413000753-mainDownload
-
-
Global Specialty Enzymes Industry 2015
Pharma Live, , Regulatory Affairs, 0
NEW YORK, June 4, 2015 /PRNewswire/ — This report analyzes the worldwide markets for Specialty Enzymes in US$ Million...
-
-
FDA awards $19m in rare disease grants – Courtesy ( PMLiVe)
Pharma Live, , Regulatory Affairs, 0
The US FDA is to encourage research in rare diseases through 15 grants totalling more than $19m. The regulator...
-
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective☆
Pharma Live, , Regulatory Affairs, 0
1-s2-0-s0169409x07003195-main-1Download
-
Pharmaceutical industry regulation undermines NICE drugs appraisal work – Courtesy (Pharmanews.eu)
Pharma Live, , Regulatory Affairs, 0
Government policies that support UK pharmaceutical science and enhance export income are costing the NHS millions and undermine the...